Evidence map›Paper›PMID 38871562›Full record

ArticleTrends in microbiology2024

KAP1/TRIM28 - antiviral and proviral protagonist of herpesvirus biology.

Sumita Bhaduri-McIntosh, Beth A Rousseau

Abstract read
In one paragraph

Article in Trends in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. KAP1 in antiviral immunity: dual roles in viral silencing and immune regulation.Frontiers in cellular and infection microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sumita Bhaduri-McIntoshDivision of Infectious Diseases, Department of Pediatrics, University of Florida, Gainesville, FL, USA; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, USA. Electronic address: sbhadurimcintosh@ufl.edu.
Beth A RousseauDivision of Infectious Diseases, Department of Pediatrics, University of Florida, Gainesville, FL, USA.

Funding

Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIVU01CA275310 · NCI · UNIVERSITY OF FLORIDA · PI SUMITA BHADURI-MCINTOSH, Michael T McIntosh · 2022 to 2026
$3.7M
Exposing synthetic lethal vulnerabilities in EBV-positive AIDS-NHL through novel replication dependency factorsR01DE032623 · NIDCR · UNIVERSITY OF FLORIDA · PI SUMITA BHADURI-MCINTOSH · 2023 to 2026
$2.4M
Host determinants of Epstein-Barr virus lytic cycle activationR01AI113134 · NIAID · UNIVERSITY OF FLORIDA · PI BHADURI-MCINTOSH, SUMITA · 2014 to 2018
$1.9M
NCI NIH HHS U01 CA275310NIAID NIH HHS R01 AI113134NIDCR NIH HHS R01 DE032623
6 · The paper itself

Abstract

Dysregulation of the constitutive heterochromatin machinery (HCM) that silences pericentromeric regions and endogenous retroviral elements in the human genome has consequences for aging and cancer. By recruiting epigenetic regulators, Krüppel-associated box (KRAB)-associated protein 1 (KAP1/TRIM28/TIF1β) is integral to the function of the HCM. Epigenetically silencing DNA genomes of incoming herpesviruses to enforce latency, KAP1 and HCM also serve in an antiviral capacity. In addition to gene silencing, newer reports highlight KAP1's ability to directly activate cellular gene transcription. Here, we discuss the many facets of KAP1, including recent findings that unexpectedly connect KAP1 to the inflammasome, reveal KAP1 cleavage as a novel mode of regulation, and argue for a pro-herpesviral KAP1 function that ensures transition from transcription to replication of the herpesvirus genome.

Indexed as

HerpesviridaeTripartite Motif-Containing Protein 28Virus LatencyVirus ReplicationAnimalsEpigenesis, GeneticGene SilencingHerpesviridae InfectionsHeterochromatinHumansInflammasomesProvirusesHeterochromatinInflammasomesTRIM28 protein, humanTripartite Motif-Containing Protein 28herpesvirusheterochromatinKAP1latencyreactivationTRIM28

Identifiers

PMID38871562
PMCPMC11620967

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.